INTEGRATED BIOPHARMA INC (INBP) Operating income 2016–2025
INTEGRATED BIOPHARMA INC (INBP) annual operating income history from SEC filings — each fiscal year as reported.
$2.0MFY2025 · since FY2016: $2.1M → $2.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $2.0M | +704.8% |
| FY2024 | $251,000 | +109.2% |
| FY2023 | $120,000 | -95.6% |
| FY2022 | $2.7M | -52.5% |
| FY2021 | $5.8M | +77.5% |
| FY2020 | $3.3M | +20.5% |
| FY2019 | $2.7M | +59.6% |
| FY2018 | $1.7M | -46.8% |
| FY2017 | $3.2M | +50.8% |
| FY2016 | $2.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice